# The Real-world Firebird 2 Versus Cypher Sirolimus-eluting Stent in Treating Patients With Coronary Artery Disease

> **NCT01328730** · PHASE4 · WITHDRAWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 430 (estimated)

## Conditions studied

- Coronary Artery Stenosis

## Interventions

- **DEVICE:** Firebird 2 SES
- **DEVICE:** Cypher SES

## Key facts

- **NCT ID:** NCT01328730
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-04
- **Primary completion:** 2012-03
- **Final completion:** 2013-06
- **Target enrollment:** 430 (ESTIMATED)
- **Why stopped:** the Cypher SES is now withdrawing in China market
- **Last updated:** 2011-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328730, "The Real-world Firebird 2 Versus Cypher Sirolimus-eluting Stent in Treating Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01328730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*